XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Compensation
9 Months Ended
Sep. 30, 2020
Stock Compensation [Abstract]  
Stock Compensation

Note 6 – Stock Compensation 



The Company uses the fair value method of accounting for share-based compensation arrangements. The fair value of stock options is estimated at the date of grant using the Black-Scholes option valuation model. Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method. 



The following table summarizes the allocation of non-cash stock-based compensation to our expense categories for the three and nine months ended September 30, 2020 and 2019 (in thousands): 









 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Nine Months Ended



 

September 30,

 

September 30,



 

2020

 

2019

 

2020

 

2019

Cost of revenues

 

$

 

$

 

$

14 

 

$

20 

Research and development

 

 

 

 

21 

 

 

42 

 

 

66 

Selling, general and administrative

 

 

51 

 

 

137 

 

 

91 

 

 

369 

Total stock compensation expense

 

$

60 

 

$

164 

 

$

147 

 

$

455 



At September 30, 2020, total unrecognized compensation costs related to stock options was approximately $36 thousand, net of estimated forfeitures. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures and is expected to be recognized over a weighted average period of approximately 0.9 years.



The following key assumptions were used in the Black-Scholes option pricing model to determine the fair value of stock options granted: 







 

 

 

 

 

 



Nine Months Ended



September 30,



2020

 

2019

Dividend yield

 

 %

 

 %

Risk free interest rates

 

0.3 

 %

 

1.77 - 2.48

 %

Expected volatility

 

46.1 

 %

 

41.7 to 49.2

 %

Expected term (in years)

 

 

 

3.5 to 4.0

 



The Company does not expect to pay dividends in the near future. Therefore, the Company used an expected dividend yield of 0%. The risk-free interest rate used in the Black-Scholes option pricing model is based on applicable yield available at the date of the option grant on U.S. Treasury securities with an equivalent term. Expected volatility is based on the weighted average historical volatility of the Company’s common stock for the equivalent term. The expected term of the options represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience and vesting schedules of similar awards. 



A summary of the Company’s stock option activity for nine months ended September 30, 2020, presented in the following table (unaudited)







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Number of
Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Life (In Years)

 

Aggregate
Intrinsic
Value

Outstanding at December 31, 2019

 

 

5,404,985 

 

$

2.40 

 

 

 

 

 

 

Options granted

 

 

150,000 

 

 

0.83 

 

 

 

 

 

 

Options exercised

 

 

 —

 

 

 —

 

 

 

 

 

 

Options forfeited

 

 

 —

 

 

 —

 

 

 

 

 

 

Options cancelled or expired

 

 

(682,151)

 

 

3.39 

 

 

 

 

 

 

Outstanding at September 30, 2020

 

 

4,872,834 

 

$

2.36 

 

 

3.00 

 

$

 —

Vested or expected to vest at September 30, 2020 (1)

 

 

4,872,133 

 

$

2.36 

 

 

3.00 

 

$

 —

Exercisable at September 30, 2020

 

 

4,837,833 

 

$

2.22 

 

 

2.98 

 

$

 —

(1)

The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.



The aggregate intrinsic value in the table above represents the difference between the exercise price of the underlying options and the quoted price of the Company’s common stock. The aggregate intrinsic value of options exercised was zero for the three and nine months ended September 30, 2020. The Company issues new shares of common stock upon exercise of stock options.